On 18th November, the new product launch of Hengan Fulin Lidian® Collagen Patch Dressing was successfully closed at the headquarters of Jingdong Health in Beijing.Leaders and experts from various parties witnessed this launch. This project is the first Class III medical device incubated by Healtech CDMO Center based on the whole process of ‘Marketing Authorization solution’ and formally entered into the commercialisation stage, which has an important milestone significance.It is the world's first new product that applies new medical material Extracellular Matrix (ECM) to the field of medical aesthetics in a large-scale and industrialised manner, and it sets off the clinical application of extracellular matrix . 

Hengan Florine and Healtech's core executives witnessed this important milestone together.

Healtech’s Tissue Engineering and Regenerative Medicine Biomaterials Laboratory, which undertakes the special project of "National 13th Five Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", realizing the transformation of scientific and technological achievements in "Engineering preparation technology and product development of low immunogenicity collagen and silk fibroin protein". We have mastered the core patented technology of extracellular matrix (ECM) and silk Fibroin (SFM), and further reserving various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.

The tissue Engineering and Regenerative Medicine Biomaterials Laboratory has reserved more than 80 technical projects, has applied for 37 national invention patents, has obtained 12 national invention patent certificates and 6 medical device registration certificates, and we can provide technical upgrading and new project reserve services for production-type and sales-type enterprises. At present we has established strategic cooperative partnership with a number of domestic and foreign pharmaceutical and medical device listed companies, such as Fosun Pharma, SL Pharm, and Soyang Group.

The successful commercialisation of Hengan Fulin ECM Collagen Patch Dressing has verified that Healtech Marketing Authorization solution has the professional ability to realise the product from scientific research to industrialisation and finally commercialisation, and can carry the important mission of transforming scientific and technological achievements.